SATO Pharmaceutical Co., Ltd.
1 clinical trials · Sponsor
◉ Watch SATO Pharmaceutical Co., Ltd.
| Record | Firm | Date |
|---|---|---|
| Safety and Tolerability Study of SKX-16 in Subjects With Moderate to Severe Distal Subungual Onychomycosis (NCT05110638) | SATO Pharmaceutical Co., Ltd. | 2021-09-22 |
Track SATO Pharmaceutical Co., Ltd. automatically
Every clearance here is in the API, with alerts when new ones post.